Results 61 to 70 of about 5,983,116 (281)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Pandemic influenza preparedness guide for retail food establishments

open access: yes, 2006
Title from PDF cover (viewed Dec. 21, 2006).; "This Guide was developed by a partnership between the Ohio Department of Health and the Ohio Food Industry Foundation. Funding was provided by the Centers for Disease Control (CDC).
Ohio Food Industry Foundation.
core  

Time to relect- Irish Hospice Foundation survey about death, dying and bereavement during the COVID-19 pandemic

open access: yes, 2023
The Time to Reflect survey was commissioned by Irish Hospice Foundation to explore the impact of COVID-19 on the experiences and perceptions of the Irish population in relation to dying, death, and bereavement during this time.
Irish Hospice Foundation
core  

Quality and reliability of IFC/BIM models for public educational facilities construction projects via clash detection

open access: yesJournal of Civil Engineering and Management
This study investigates the reliability of monodiscipline IFC/BIM models in public construction projects of educational facilities through advanced clash detection and quantitative analysis. Data were collected from BIM models of two kindergartens and a
Michał Juszczyk   +5 more
doaj   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

NPS Alumni Association & Foundation (archived) [PDF]

open access: yes, 2019
The NPS Foundation is a non­profit organization dedicated to supporting the mission of the Naval Postgraduate School and its students, faculty and staff.
Naval Postgraduate School Foundation
core   +2 more sources

Automatic Generation of High-Accuracy Stair Paths for Straight, Spiral, and Winder Stairs Using IFC-Based Models

open access: yesISPRS International Journal of Geo-Information, 2020
The indoor space model is the foundation of most indoor location-based services (LBS). A complete indoor space model includes floor-level paths and non-level paths.
Will Y. Lin
doaj   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy